RxDoctor Payments Data

Andrea Hughes, DO

Family Medicine · Sherman, TXNPI 1124516802

Payments from drug & device makers

$685in general payments, 2019–2025

Across 32 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$234
  • Otsuka America Pharmaceutical, Inc.$96
  • AstraZeneca$65
  • Astellas Pharma US Inc$53
  • Amgen$50
  • Exact Sciences$45
  • plus $142 from 9 others

What the payments were for

  • Food & beverage$685100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$685 in reported general payments places this provider in the 55th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$35,676
Medicare patients
72
Services billed
495

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$91,146
OzempicSemaglutide77$81,401
FarxigaDapagliflozin Propanediol23$25,436
JanuviaSitagliptin Phosphate21$22,343
EliquisApixaban11$10,102
Tresiba Flextouch U-200Insulin Degludec16$9,864
SymbicortBudesonide/Formoterol Fumarate16$3,706
Gabapentin72$1,595
Levothyroxine Sodium79$1,409
Atorvastatin Calcium149$1,267
Estradiol41$968
Albuterol Sulfate HfaAlbuterol Sulfate44$947
Trazodone Hcl59$831
Losartan Potassium74$786
Ibuprofen25$739

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$13$91,14612 claims
Novo NordiskOzempic$234$81,40177 claims
AstraZenecaFarxiga, Symbicort$65$29,14239 claims
PfizerEliquis$18$10,10211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Sherman

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →